Simcere Pharmaceutical Group Limited (HKG:2096)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
11.51
+0.18 (1.59%)
Mar 5, 2026, 4:08 PM HKT
48.13%
Market Cap 29.29B
Revenue (ttm) 7.79B
Net Income (ttm) 964.48M
Shares Out 2.58B
EPS (ttm) 0.39
PE Ratio 28.89
Forward PE 20.36
Dividend 0.18 (1.60%)
Ex-Dividend Date Jun 18, 2025
Volume 6,840,000
Average Volume 5,594,420
Open 11.77
Previous Close 11.33
Day's Range 11.31 - 11.84
52-Week Range 7.07 - 15.08
Beta 0.90
RSI 41.64
Earnings Date Mar 20, 2026

About HKG:2096

Simcere Pharmaceutical Group Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China. The company focuses on various therapeutic areas, including oncology, central nervous system, autoimmune, anti-infection, cardiovascular, and others. Its principal products include Sanbexin, an edaravone and dexborneol concentrated solution for injection; Endostar, a recombinant human endostatin injection; ENW... [Read more]

Sector Healthcare
Founded 1995
Employees 6,815
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2096
Full Company Profile

Financial Performance

In 2024, HKG:2096's revenue was 6.64 billion, an increase of 0.41% compared to the previous year's 6.61 billion. Earnings were 733.17 million, an increase of 2.57%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.